HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: Exacerbation by inflammatory cytokines and amelioration by antioxidants

Cardiovascular Toxicology

Volumn 4, Issue 3, 2004, Pages 287-302

  Mondal, Debasis ^a   Pradhan, Leena ^a   Ali, Mussa ^a   Agrawal, Krishna C ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adhesion molecules; Antioxidants; Endothelium; HAART drugs; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ANTIRETROVIRUS AGENT; CELL ADHESION MOLECULE; CYTOKINE; EFAVIRENZ; GLUTATHIONE; INDINAVIR; INTERCELLULAR ADHESION MOLECULE 1; NELFINAVIR; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ZIDOVUDINE;

AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; DIABETES MELLITUS; DISEASE EXACERBATION; ENDOTHELIUM CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT;

ACETYLCYSTEINE; ANTIOXIDANTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GLUTATHIONE; HUMANS; INDINAVIR; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; NELFINAVIR; OXAZINES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 6044220126     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:4:3:287     Document Type: Article

References (38)

1. Carr, A. (2003). Cardiovascular risk factors in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 34:S73-S78.
2. Barthelemy, O., Escaut, L., Vayre, F., Gallet, B., Pulik, M., Heliore, F., et al. (2002). Acute coronary syndromes in patients treated with HIV protease inhibitors. Presse. Med. 31:343-348.
3. Carr, A. (2003). HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 17:S141-S148.
4. Rubanyi, G.M. (1993). The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 22:S1-S14.
5. Gonzalez-Amaro, R., Diaz-Gonzalez, P., and Sanchez-Madrid, F. (1998). Adhesion molecules in inflammatory diseases. Drugs 56:977-988.
6. Collins, T., Read, M.A., Neish, A.S., Whitley, M.Z., Thanos, D., and Maniatis, T. (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899-909.
7. Walia, M., Samson, S.E., Schmidt, T., Best, K., Kwan, C.Y., and Grover, A.K. (2003). Effects of peroxynitrite on pig coronary artery smooth muscle. Cell Calcium 34:69-74.
8. Moskowitz, R. and Kukin, M. (1999). Oxidative stress and congestive heart failure. Congest. Heart Fail. 5:153-163.
9. Chen, K.H., Reece, L.M., and Leary, J.F. (1999). Mitochondrial glutathione modulates TNF-alpha-induced endothelial cell dysfunction. Free Radic. Biol. Med. 27:100-109.
10. 2 and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol 286:H1001-H1007.
11. Gupta, B. and Ghosh, B. (1999). Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int. J. Immunopharmacol. 21:745-757.
12. Mondal, D. and Agrawal, K.C. (1996). Effect of HIV type 1 Tat protein on butyric acid-induced differentiation in a hematopoietic progenitor cell line. AIDS Res. Hum. Retroviruses 12:1529-1536.
13. Barbara, G. (2003). HlV infection, highly active antiretroviral therapy and the cardiovascular system. Cardiovasc. Res. 60:87-95.
14. Eissner, G., Kolch, W., Mischak, H., Bornkamm, G.W., and Holler, E. (1994). Differential role of protein kinase C in cytokine induced lymphocyte-endothelium interaction in vitro. Scand. J. Immunol. 40:395-402.
15. Deisher, T.A., Haddix, T.L., Montgomery, K.F., Pohlman, T.H., Kaushansky, K., and Harlan, J.M. (1993). The role of protein kinase C in the induction of VCAM-1 expression on human umbilical vein endothelial cells. FEBS Lett. 331:285-290.
16. Scott-Algara, D., Vuillier, P., Marasescu, M., de Saint Martin, J., and Dighiero, G. (1991). Serum levels of IL-2, IL-1α, TNF-α, and soluble receptor of IL-2 in HIV-1-infected patients. AIDS Res. Hum. Retroviruses 7:381-386.
17. Bilello, J.A., Stellrecht, K., Drusano, G.L., and Stein, D.S. (1996). Soluble tumor necrosis factor-alpha receptor type II (sTNF-αRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J. Infect. Dis. 173:464-467.
18. Medrano, F.J., Rey, C., Leal, M., Canavate, C., Rubio, A., Sanchez-Quijano, A., et al. (1998). Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clin. Exp. Immunol. 114:403-407.
19. Jialal, I., Devaraj, S., and Venugopal, S.K. (2002). Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic. Res. 36:1331-1336.
20. Hsiai, T.K., Cho, S.K., Wong, P.K., Ing, M., Salazar, A., Sevanian, A., et al. (2003). Monocyte recruitment to endothelial cells in response to oscillatory shear stress. FASEB J. 17:1648-1657.
21. Mondal, D., Larussa, V.F., and Agrawal, K.C. (2001). Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases. AIDS Res. Hum Retroviruses 17:1569-1584.
22. Caron, M., Auclair, M., Sterlingot, H., Kornprobst, M., and Capeau, J. (2003). Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. AIDS 17:2437-2444.
23. Blankenberg, S., Barbaux, S., and Tiret, L. (2003). Adhesion molecules and atherosclerosis. Atherosclerosis 170:191-203.
24. Alcoba, M., Cuevas, M.J., Perez-Simon, M.R., Mostaza, J.L., Ortega, L., Ortiz de Urbina, J., et al. (2003). Assessment of adherence to triple antiretroviral treatment including indinavir: role of the determination of plasma levels of indinavir. J. Acquir. Immune Defic. Syndr. 33:253-258.
25. Calza, L., Manfredi, R., and Chiodo, F. (2003). Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management. Int. J. Antimicrob. Agents 22:89-99.
26. AIDS Info, http://aidsinfo.nih.gov/guidelines. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. July 14, 2003; 55.
27. Zahler, S., Kupatt, C., and Becker, B.F. (2000). Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-alpha. FASEB J. 14:555-564.
28. Chaudiere, J., Moutet, M., and D'Alessio, P. (1995). Anti-oxidants and anti-inflammatory protection of vascular endothelial cells by new synthetic mimics of glutathione peroxidase. C R Seances Soc. Biol. Fil. 189:861-882.
29. Hulgan, T., Morrow, J., D'Aquila, R.T., Raffanti S., Morgan M., Rebeiro P., et al. (2003). Oxidant stress is increased during treatment of human immunodeficiency virus infection. Clin. Infect. Dis. 37:1711-1717.
30. Jareno, E.J., Roma, J., Romero, B., Marin, N., Muriach, M., Johnsen, S., et al. (2002). Serum malondialdehyde correlates with therapeutic efficiency of high activity antiretroviral therapies (HAART) in HIV-1 infected children. Free Radic. Res. 36:341-344.
31. Aukrust, P., Muller, F., Svardal, A.M., Ueland, T., Berge, R.K., and Froland, S.S. (2003). Disturbed glutathione metabolism and decreased levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy - potential immuno-modulatory effects of antioxidants. J. Infect. Dis. 188:232-238.
32. Capaldini, L. (1997). Protease inhibitors' metabolic side effects: cholesterol, triglycerides, blood sugar, and "Crix belly." Interview with Lisa Capaldini, M.D. Interview by John S. James. AIDS Treat. News 277:1-4.
33. Calista, D. and Boschini, A. (2000). Cutaneous side effects induced by indinavir. Eur. J. Dermatol. 10:292-296.
34. Birdsall, H.H., Siwak, E.B., Trial, J., Rodriguez-Barradas, M., White, A.C. Jr., Wietgrefe, S., et al. (2002). Trans-endothelial migration of leukocytes carrying infectious HIV-1: an indicator of adverse prognosis. AIDS 16:5-12.
35. Arroyo, A.G., Garcia-Vicuna, R., Marazuela, M., Yednock, T.A., Gonzalez-Amaro, R., and Sanchez-Madrid, F. (1995), Expression and functional significance of an activation-dependent epitope of the beta 1 integrins in chronic inflammatory diseases. Eur. J. Immunol. 25:1720-1728.
36. Kalogeris, T.J., Kevil, C.G., Laroux, F.S., Coe, L.L., Phifer, T.J., and Alexander, J.S. (1999). Differential mono-cyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am. J. Physiol. 276: L9-L19.
37. Kvietys, P.R. and Granger, D.N. (1997). Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am. J. Physiol. 273:G1189-G1199. (Review).
38. Panes, J., Perry, M.A., Anderson, D.C., Manning, A., Leone, B., Cepinskas, G., et al. (1995). Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. J. Physiol. 269:H1955-H1964.